Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A systematic review of community based hepatitis C treatment.

BMC infectious diseases - 16 May 2016

Wade Amanda J, Veronese Vanessa, Hellard Margaret E, Doyle Joseph S

Abstract excerpt

BACKGROUND: Hepatitis C virus (HCV) treatment uptake globally is low. A barrier to treatment is the necessity to attend specialists, usually in a tertiary hospital. We investigate the literature to assess the effect of providing HCV treatment in the community on treatment uptake and cure. METHODS: Three databases were searched for studies that contained a comparison between HCV treatment uptake or sustained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interferon-alpha
Share to Ribavirin
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepacivirus

Share to Hepatitis C

Share to Tertiary Care Centers

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 27184661
DOI: 10.1186/s12879-016-1548-5
PMCID: PMC4867528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A systematic review of community based hepatitis C treatment.PMID 27184661Read ↗

Development and implementation of site-specific Hepatitis C Virus treatment workflows for treating vulnerable, high-risk populations: protocol of the Erase Hep C study, a prospective single-arm intervention trialSemantic proximity Read ↗

Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.Semantic proximity Read ↗

Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil.Semantic proximity Read ↗

Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.Semantic proximity Read ↗

What is the impact of a country-wide scale-up in antiviral therapy on the characteristics and sustained viral response rates of patients treated for hepatitis C?Semantic proximity Read ↗

Outcomes of Pharmacist-Led Treatment of Hepatitis C in the Virginia Department of Corrections.Semantic proximity Read ↗

Hepatitis C in an urban cohort: who's not being treated?Semantic proximity Read ↗

Delivery of treatment for hepatitis C virus infection in the primary care setting.Semantic proximity Read ↗

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia.Semantic proximity Read ↗

Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.Semantic proximity Read ↗

Improving access to hepatitis C care for urban, underserved patients using a primary care-based hepatitis C clinic.Semantic proximity Read ↗

Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.